AAPL 153.04 +0.34 (+0.22%)MSFT 105 +0.23 (+0.22%)FB 130.65 -2.52 (-1.89%)ZNGA 3.95 +0.07 (+1.68%)NVDA 133.37 -0.29 (-0.22%)WBA 68.22 +0.16 (+0.24%)GOOG 1029.8 -7.78 (-0.75%)PIH 4.14 +0.25 (+6.43%)
AAPL 153.04 +0.34 (+0.22%)MSFT 105 +0.23 (+0.22%)FB 130.65 -2.52 (-1.89%)ZNGA 3.95 +0.07 (+1.68%)NVDA 133.37 -0.29 (-0.22%)WBA 68.22 +0.16 (+0.24%)GOOG 1029.8 -7.78 (-0.75%)PIH 4.14 +0.25 (+6.43%)

Financial Summary CRSP Quote CRISPR Ther

CRISPR Therapeutics AG Quote

CRISPR Therapeu (CRSP)

29.48 2.78 Healthcare
Stock Performance rating :
Recommendation :
Strong Sell
Score :
C-
Symbol CRSP
Price 29.48
Beta 2.26
Vol Avg 1.15 M
Mkt cap 2.49 B
Shares 40
Last Div Not Available
Div Yield 0.00%
DCF Unlevered 0.00
DCF Levered 0.00
ROE -75.14% Strong Sell
ROA -49.82% Strong Sell
Operating Margin -158.54% Strong Sell
Debt/Equity 44.68% Neutral
P/E -17.34 Strong Sell
P/B 6.27 Strong Buy
Company Profile

CEO

Samarth Kulkarni

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ Global Market

Description

CRISPR Therapeutics AG is a gene editing company. It is engaged in the development of CRISPR/Cas9-based therapeutics.